Skip to main content
SpringerLink
Log in

Antiretrovirale Therapie (ART) und Nervensystem

  • Conference paper
HIV-Infekt

  • 174 Accesses

Zusammenfassung

Die Beziehung zwischen antiretroviraler Therapie (ART) respektive hochaktiver antiretroviraler Therapie (HAART) und Nervensystem (NS) von HIV-1-Infizierten ist nicht nur durch Behandlungsindikationen und nervale Strukturen affizierende Nebenwirkungen, sondern auch durch Interaktionen gängiger, in der Neurologie angewendeter Medikamente mit antiretroviral wirksamen Substanzen geprägt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Arendt G, Giesen HJv, Jablonowski H (1998) Stavudine stops Neuro-AIDS in AZT Non-Responders. In: 12th World AIDS Conference. Geneva, Switzerland

    Google Scholar 

  2. Arendt G, Hefter H, Buescher L, Hilperath F, Elsing C, Freund HJ (1992) Improvement of motor performance of HIV-positive patients under AZT therapy. Neurology 42: 891–896

    PubMed  CAS  Google Scholar 

  3. Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund HJ (1990) Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. Journal of Neurology 237: 362–368

    Article  PubMed  CAS  Google Scholar 

  4. Blum AS, Dal Pan GJ, Feinberg J, Raines C, Mayjo K, Cornblath DR, McArthur JC (1996) Low-dose zalcitabine-related toxic neuropathy: Frequency, natural history, and risk factors. Neurology 46: 999–1003

    PubMed  CAS  Google Scholar 

  5. Childs EA, Lyles RH, Seines OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC (1999) Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52: 607–613

    PubMed  CAS  Google Scholar 

  6. Corey L, Holmes KK (1996) Therapy for Human Immunodeficiency Virus Infection - What have we learned? The New England Journal of Medicine 335: 1142–1144

    Article  PubMed  CAS  Google Scholar 

  7. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA (1997) Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Annals of Neurology 42: 679–688

    Article  PubMed  CAS  Google Scholar 

  8. Giesen HJv, Hefter H, Jablonowski H, Arendt G (1999) Stavudine (2’,3’-Didehydro-3’deoxythymidine; D4T) and the peripheral nerve in HIV-1-infected patients. Journal of Neurology 246: 211–217

    Article  Google Scholar 

  9. Glass JD, Wesselingh SL (1998) Viral load in HIV-associated dementia. Annals of Neurology 44: 150–151

    Article  PubMed  CAS  Google Scholar 

  10. Haworth SJ, Christofalo B, Anderson RD, Dunkle LM (1998) A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults. J Acquir Immune Defic Syndr Hum Retrovirol 17: 235–238

    Article  PubMed  CAS  Google Scholar 

  11. Klecker RW, Jr., Collins JM, Yarchoan R, Thomas R, Jenkins JF, Broder S, Myers CE (1987) Plasma and cerebrospinal fluid pharmacokinetics of 3’-azido-3’-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin Pharmacol Ther 41: 407–412

    Article  PubMed  Google Scholar 

  12. Maj M (1996) Depressive syndromes and symptoms in subjects with human immunodeficiency virus (HIV) infection. Br J Psychiatry Suppl 1996: 117–122

    Google Scholar 

  13. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582–1586

    Article  PubMed  CAS  Google Scholar 

  14. Robertson K, Fiscus S, Kapoor C, Robertson W, Schneider G, Shepard R, Howe L, Silva S, Hall C (1998) CSF, plasma viral load and HIV associated dementia. J Neurovirol 4: 90–94

    Article  PubMed  CAS  Google Scholar 

  15. Rolinski B, Bogner JR, Sadri I, Wintergerst U, Goebel FD (1997). Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-i-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 15: 192–197

    Article  PubMed  CAS  Google Scholar 

  16. Sacktor NC, Bacellar H, Hoover DR, Nance-Sproson TE, Seines OA, Miller EN, Dal Pan GJ, Kleeber- ger C, Brown A, Saah A, McArthur JC (1996) Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 2: 404–410

    Article  PubMed  CAS  Google Scholar 

  17. Schmider J, Greenblatt DJ, von Moltke LL, Harmatz JS, Shader RI (1995) N-demethylation of ami- triptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors. J Pharmacol Exp Ther 275: 592–597

    PubMed  CAS  Google Scholar 

  18. Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL (1988) Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319: 1573–1578

    Article  PubMed  CAS  Google Scholar 

  19. Van Cleef GF, Fisher EJ, Polk RE (1997) Drug interaction potential with inhibitors of HIV protease. Pharmacotherapy 17: 774–778

    PubMed  Google Scholar 

  20. Yang Z, Brundage RC, Barbhaiya RH, Sawchuk RJ (1997) Microdialysis Studies of the Distribution of Stavudine into the Central Nervous System in the Freely-Moving Rat. Pharmaceutical Research 14: 865–872

    Article  PubMed  Google Scholar 

Download references

Authors
  1. G. Arendt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Dermatologie, Allergologie und Venerologie, Ruhr-Universität Bochum, Gudrunstraße 56, Deutschland

    Norbert H. Brockmeyer , Klaus Hoffmann , G. Reimann , Markus Stücker  & Peter Altmeyer , , ,  & 

  2. Medizinische Klinik III, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland

    R. Brodt

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Arendt, G. (2000). Antiretrovirale Therapie (ART) und Nervensystem. In: Brockmeyer, N.H., Hoffmann, K., Reimann, G., Stücker, M., Altmeyer, P., Brodt, R. (eds) HIV-Infekt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59683-4_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59683-4_34

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64082-7

  • Online ISBN: 978-3-642-59683-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation